What questions should be asked during a psych evaluation to assess moods and behaviors in adolescent kids prior to prescribing medications like fluoxetine (selective serotonin reuptake inhibitor - SSRI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Key Questions for Adolescent Psychiatric Evaluation Prior to SSRI Medication

When evaluating adolescents for mood disorders prior to prescribing medications like fluoxetine, clinicians should use a structured approach that includes specific screening questions for depression, suicidality, and comorbid conditions.

Depression Screening Questions

Core Mood Assessment

  • "Have you ever felt so upset that you wished you were not alive or wanted to die?" 1
  • "Did you ever do something that you knew was so dangerous that you could get hurt or killed by doing it?" 1
  • "Did you ever hurt yourself or try to hurt yourself?" 1
  • "Did you ever try to kill yourself?" 1
  • "Did you ever think about or try to commit suicide?" 1

Mood Changes and Symptoms

  • Ask about distinct periods of mood changes associated with sleep disturbances and psychomotor activation 1
  • Assess for irritability rather than depressed mood as the main manifestation in adolescents 1
  • "Aside from [already stated non-mental health concern], how have you been doing?" 1
  • "What kinds of things have been on your mind or stressing you lately?" 1
  • "How have things been going with [school, friends, parents, sports]?" 1

Validated Screening Tools

Recommended Screening Instruments

  • Patient Health Questionnaire-9: Modified for Teens (PHQ-9) with a cut-point of 11 (sensitivity 89.5%, specificity 77.5%) 1
  • Patient Health Questionnaire-2 (PHQ-2) with a cut score of 3 (sensitivity 73.7%, specificity 75.2%) 1

Suicide Risk Assessment

Suicide Intent Evaluation

  • Assess suicide plans: "If you were to kill yourself, how would you do it?" 1
  • Determine if there are firearms in the home 1
  • Evaluate the family's response to suicidal thoughts 1
  • Assess motivating feelings (attention-seeking, desire to change relationships, wish to rejoin deceased relatives, escape from intolerable situations, revenge) 1

Risk Factors for Suicide

  • Previous suicide attempts 1
  • Male gender 1
  • Increasing age 1
  • Living alone (runaway, homeless, isolated) 1
  • Attempts with methods other than ingestion or superficial cutting 1
  • Steps taken to avoid detection 1

Bipolar Disorder Screening

Bipolar Symptoms

  • Screen for distinct, spontaneous periods of mood changes with sleep disturbances and psychomotor activation 1
  • Assess for family history of mood disorders 1
  • Evaluate symptoms of irritability, reckless behaviors, or increased energy 1
  • Look for manic grandiosity and irritability that present as marked changes in mental/emotional state 1

Pre-Medication Assessment

Treatment Considerations

  • For moderate to severe depression, combination treatment with medication and psychotherapy is recommended 2
  • Fluoxetine is the first-line SSRI for adolescents with major depressive disorder 2, 3
  • Initial dosing for adolescents should be 10 mg daily for 1 week, then increased to 20 mg daily 3
  • Weekly monitoring during the first 4 weeks of treatment is essential 2

Important Clinical Pearls

Diagnostic Pitfalls

  • Manic-like symptoms of irritability and emotional reactivity may be found in multiple conditions, including disruptive behavior disorders, PTSD, and pervasive developmental disorders 1
  • Behavioral and emotional reactions to psychosocial stressors may be mistaken as symptoms of an underlying biological illness 1
  • Adolescents may disclose information about suicidality on self-report that they deny in person 1

Confidentiality Considerations

  • Although confidentiality is important in adolescent health care, safety takes precedence over confidentiality for adolescents at risk to themselves or others 1
  • Explain to the adolescent that confidentiality has limits when safety is concerned 1

Follow-up Planning

  • Plan for weekly monitoring during the first 4 weeks of treatment 2
  • Use standardized symptom rating scales to track progress 2
  • Monitor for adverse effects, particularly suicidal ideation/behavior and activation syndrome 2

By using this structured approach to psychiatric evaluation, clinicians can thoroughly assess adolescents' mood and behavior before initiating SSRI treatment, ensuring appropriate diagnosis and treatment planning while prioritizing patient safety.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Pediatric Depression

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.